A detailed history of Armistice Capital, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 4,330,000 shares of AIM stock, worth $995,900. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,330,000
Previous 4,078,000 6.18%
Holding current value
$995,900
Previous $1.51 Million 22.48%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.24 - $0.42 $60,480 - $105,840
252,000 Added 6.18%
4,330,000 $1.17 Million
Q2 2024

Aug 14, 2024

BUY
$0.35 - $0.61 $1.43 Million - $2.49 Million
4,078,000 New
4,078,000 $1.51 Million

Others Institutions Holding AIM

About AIM ImmunoTech Inc.


  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $11.1M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.